Provided by Tiger Trade Technology Pte. Ltd.

ADiTx Therapeutics

1.17
-0.2900-19.86%
Pre-market: 1.13-0.0400-3.42%09:20 EST
Volume:2.30M
Turnover:2.87M
Market Cap:2.08M
PE:0.00
High:1.48
Open:1.48
Low:1.02
Close:1.46
52wk High:4,463.50
52wk Low:0.7044
Shares:1.78M
Float Shares:1.78M
Volume Ratio:0.17
T/O Rate:129.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4,919.3423
EPS(LYR):-346,053.3627
ROE:-282.21%
ROA:-61.70%
PB:-0.27
PE(LYR):0.00

Loading ...

Evofem Biosciences Inc: Delivered Notice of Termination to Aditxt Notifying That Co Was Exercising Its Right to Terminate Merger Agreement

THOMSON REUTERS
·
Oct 21, 2025

Press Release: Evofem Announces Voting Results from Special Meeting of Stockholders

Dow Jones
·
Oct 21, 2025

ADiTx Inc. Files Initial Statement of Beneficial Ownership for Christopher Jon Porcelli, General Counsel, CPO & CS

Reuters
·
Oct 03, 2025

ADiTx Inc. Files Initial Statement of Beneficial Ownership for Director Sylvia Hermina

Reuters
·
Sep 30, 2025

ADiTx Inc. Held Annual Meeting of Stockholders

Reuters
·
Sep 25, 2025

BRIEF-Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting

Reuters
·
Sep 09, 2025

Evofem Anticipates Approval of Merger With Aditxt at Upcoming Stockholder Meeting

THOMSON REUTERS
·
Sep 09, 2025

ADiTx Inc. Updates Merger Agreement with Evofem, Adjusts Equity Investment Dates and Amounts

Reuters
·
Aug 28, 2025

BRIEF-Aditxt Inc - Adimune Plans FDA Submission For Trials In Early 2026

Reuters
·
Aug 25, 2025

Aditxt Inc - Adimune Plans FDA Submission for Trials in Early 2026

THOMSON REUTERS
·
Aug 25, 2025

Adimune, Subsidiary of ADiTx Inc., Advances Immune System Reprogramming with Robust Patent Portfolio

Reuters
·
Aug 25, 2025

Aditxt Inc. Partners with Crypto.com for Custodial Crypto Account and ADTX Share Access

Reuters
·
Aug 11, 2025

Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce Adtx Share Access on Crypto.com as Part of the Larger Bitxbio™ Initiative

THOMSON REUTERS
·
Aug 11, 2025

ADiTx Inc. Announces Date for 2025 Annual Meeting of Stockholders

Reuters
·
Aug 09, 2025

ADiTx Inc. Announces Board Changes: Jeffrey Runge and Saundra Pelletier to Step Down, Pelletier to Join Adifem Post-Merger

Reuters
·
Aug 09, 2025

Pearsanta, Subsidiary of Aditxt Inc., Plans IPO with Spartan Capital to Advance Cancer Detection Technology

Reuters
·
Jul 29, 2025

Pearsanta, a Subsidiary of ADiTx Inc., Invited to Submit Full Proposal for U.S. Defense Department's Ovarian Cancer Research Award

Reuters
·
Jul 24, 2025

Aditxt’s Subsidiary Pearsanta Receives an Invitation to Submit Full Proposal for the U.S. Department of Defense Pilot Award for the Development of Its Mitomic® Ovarian Test

THOMSON REUTERS
·
Jul 24, 2025

ADiTx Inc. Highlights Strategic Growth and Upcoming IPO Plans in Latest Investor Presentation

Reuters
·
Jul 24, 2025

Adimune™ Takes Center Stage: Aditxt Subsidiary Targets Autoimmune Breakthroughs at Upcoming Livestream

Reuters
·
Jul 22, 2025